Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page footer’s software revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” a change related to the ClinicalTrials.gov site build rather than the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-23T21:52:45.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.2, was added to the Record History and the previous v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T12:27:11.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Record History now shows revision v3.5.0 and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:27:02.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added to the record history, and an older entry (v3.4.2) was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:19:36.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the Record History.
    Difference
    0.8%
    Check dated 2026-02-11T04:49:26.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page now displays a government funding notice at the top indicating the NIH Clinical Center is open, and the record version has been updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-04T03:41:09.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.